Price target
30.600.000.00%
The 8 analysts offering 1 year price forecasts for CN2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 8 analysts giving stock ratings to CN2 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CN2 EPS for the last quarter is 0.31 EUR despite the estimation of 0.27 EUR. In the next quarter EPS is expected to reach 0.33 EUR. Track more of CATALYST PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter CATALYST PHARMACEUTICALS INC revenue is expected to reach 128.70 M EUR. Check out CATALYST PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, CN2 price target is 30.60 EUR with a max estimate of 36.06 EUR and a min estimate of 26.57 EUR. Check if this forecast comes true in a year, meanwhile watch CATALYST PHARMACEUTICALS INC stock price chart and keep track of the current situation with CN2 news and stock market news.
We've gathered opinions of 8 analysts rating CN2 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.